- Home
- RXRX vs SPNS Comparison
RXRX vs SPNS Comparison
Compare RXRX & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- SPNS
- Stock Information
- Founded
- RXRX 2013
- SPNS 1982
- Country
- RXRX United States
- SPNS Israel
- Employees
- RXRX N/A
- SPNS N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- RXRX Health Care
- SPNS Technology
- Exchange
- RXRX Nasdaq
- SPNS Nasdaq
- Market Cap
- RXRX 2.6B
- SPNS 2.4B
- IPO Year
- RXRX 2021
- SPNS 1992
- Fundamental
- Price
- RXRX $4.99
- SPNS $43.10
- Analyst Decision
- RXRX Buy
- SPNS Hold
- Analyst Count
- RXRX 4
- SPNS 3
- Target Price
- RXRX $7.25
- SPNS $31.33
- AVG Volume (30 Days)
- RXRX 70.9M
- SPNS 479.3K
- Earning Date
- RXRX 11-05-2025
- SPNS 11-03-2025
- Dividend Yield
- RXRX N/A
- SPNS 1.39%
- EPS Growth
- RXRX N/A
- SPNS N/A
- EPS
- RXRX N/A
- SPNS 1.22
- Revenue
- RXRX $64,596,000.00
- SPNS $549,037,000.00
- Revenue This Year
- RXRX $24.17
- SPNS $8.50
- Revenue Next Year
- RXRX $20.96
- SPNS $6.83
- P/E Ratio
- RXRX N/A
- SPNS $35.32
- Revenue Growth
- RXRX 30.14
- SPNS 3.08
- 52 Week Low
- RXRX $3.79
- SPNS $23.69
- 52 Week High
- RXRX $12.36
- SPNS $43.21
- Technical
- Relative Strength Index (RSI)
- RXRX 41.80
- SPNS 68.32
- Support Level
- RXRX $5.58
- SPNS $43.02
- Resistance Level
- RXRX $5.76
- SPNS $43.15
- Average True Range (ATR)
- RXRX 0.49
- SPNS 0.07
- MACD
- RXRX -0.13
- SPNS -0.11
- Stochastic Oscillator
- RXRX 0.69
- SPNS 38.24
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.